Senseonics stock rises ~5% after hours on Q2 results beat, unchanged FY revenue guidance

Aug. 09, 2022 5:17 PM ETSenseonics Holdings, Inc. (SENS)By: Anuron Mitra, SA News Editor3 Comments

Rolled newspaper with the headline Quarterly Results


  • Shares of Senseonics (NYSE:SENS) gained 5.4% to $1.96 in Tuesday postmarket trading, after the company reported Q2 results that beat estimates and kept it FY 2022 revenue guidance unchanged.
  • Germantown, Md.-based SENS is medical device company catering to diabetics. Its flagship product

Recommended For You

Comments (3)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.